Delivery Order SPE2D019D0002-SPE2D324F068L

Award Date 6/24/24
Potential Completion Date 6/27/24
Potential Value $5.5K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Livonia, MI 48152, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to The Harvard Drug Group, L.L.C. (The Harvard Drug Group), a subsidiary of Cardinal Health, Inc. The $22,590.14 firm-fixed-price contract is for the supply of other medical products, with an ultimate completion date of January 3, 2023. The Harvard Drug Group is a leading provider of pharmaceutical products and medical supplies to the U.S. military, Department of Veterans Affairs, and other government...
The Defense Logistics Agency Troop Support Medical awarded a $10,120 delivery order to The Harvard Drug Group, L.L.C. Major Pharmaceuticals & Rugby Laboratories Division for the supply of 3,000 units of miconazole combination packs. The Harvard Drug Group, L.L.C. Major Pharmaceuticals & Rugby Laboratories Division is a subsidiary of Cardinal Health, Inc. located in Livonia, Michigan. The delivery order is a firm-fixed-price contract with performance required between July 26-31, 2023 to...
The Defense Logistics Agency Troop Support Medical awarded a $5,880 delivery order contract to The Harvard Drug Group, L.L.C. Major Pharmaceuticals & Rugby Laboratories Division for bisacodyl 5 mg delayed release tablets. The place of performance will be the prime contractor's facility located in Livonia, Michigan. The firm fixed price order is for delivery between July 18-21, 2023. Cardinal Health, Inc. is the parent company of the prime contractor. No additional subcontractors or set aside...
The Defense Logistics Agency Troop Support Medical awarded a $1.65 million firm fixed price delivery order to The Harvard Drug Group, L.L.C. Major Pharmaceuticals & Rugby Laboratories Division for 4561471302 MECLIZINE 25 MG CHEWABLE TABLET 100S. Performance will take place in Livonia, Michigan over a five-day period concluding on July 17, 2023. The prime contractor, a subsidiary of Cardinal Health, Inc., will supply the requested pharmaceutical product to the DLA Troop Support Medical in...
The Defense Logistics Agency Troop Support Medical awarded a $2,520 delivery order to The Harvard Drug Group, L.L.C. Major Pharmaceuticals & Rugby Laboratories Division for the supply of 325 mg aspirin tablets. As part of its mission to procure pharmaceuticals and medical supplies for the Department of Defense, the agency issued this firm fixed price contract for 100 count bottles of aspirin to support delivery of medical countermeasures. The prime contractor, a subsidiary of Cardinal...
This is a federal delivery order contract awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,341.30 firm-fixed-price contract is for the delivery of 20mg Methylphenidate Hydrochloride tablets, with a period of performance through June 11, 2025. The contract is not set-aside and was awarded on an open competition basis. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4568120158 - MUCUS RLF DM ER 600-30 MG TAB 40S, with a firm fixed price and a ceiling value of $1,196.79. The contract has an ultimate completion date of May 5, 2025 and was awarded on May 2, 2025. This contract is not set aside and is part of a larger Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $70,361.94 contract is for the supply of a variety of medical and pharmaceutical products, including prescription medications, medical devices, and healthcare commodities, to support the agency's medical supply chain requirements. This delivery order is part of a larger $999,999,999.00...
This is a $1,295.91 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of M-PAP 160 MG/5 ML LIQUID 120ML, a medical product, with an ultimate completion date of April 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $597,949.30, is for the provision of a variety of pharmaceutical products and medical supplies to support military healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00, which serves as a...
  • SPE2D019D0002
    Indefinite Delivery Contract
  • SPE2D019D0002-SPE2D324F068L
    Delivery Order

The U.S. Department of Defense (DoD), through the Defense Logistics Agency (DLA) Troop Support Medical, has awarded a delivery order contract worth $5,520.00 to The Harvard Drug Group, L.L.C. (The Harvard Drug Group) for the supply of MUCUS RLF DM ER 600-30 MG TAB 20S, a pharmaceutical product. This delivery order is placed against an existing Indefinite Delivery Contract (IDV) held by The Harvard Drug Group, a leading provider of pharmaceutical products and medical supplies to the federal government. The Harvard Drug Group, operating as the Major Pharmaceuticals & Rugby Laboratories Division, is a subsidiary of Cardinal Health, Inc. and is a for-profit, Native Hawaiian Organization-owned limited liability company. This contract has a firm-fixed-price pricing type and does not have any set-aside designation, indicating The Harvard Drug Group's ability to compete in unrestricted federal procurement environments. The place of performance for this contract is Livonia, Michigan, and the ultimate completion date is June 27, 2024.

Generated 9/23/24, 10:05 AM